Zelnorm (tegaserod) may come back

September 2007

Patients are hearing that Zelnorm (tegaserod) may come back....

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

vaccinating kids returning to school
Prexige (lumiracoxib) in the news
Gastroenterology Losec and Nexium might cause heart problems
Gastroenterology Humira is now officially approved by Health Canada to treat Crohn's disease
Gastroenterology Zelnorm (tegaserod) may come back
You'll soon see Campral (acamprosate) for alcohol dependence
Hematology Oncology Sativex (Cannabis sativa extract) for patients with advanced cancer will help pain relief
Psychiatry Exelon (rivastigmine) in a once-daily PATCH
Diabetes whether patients with type 2 diabetes benefit from monitoring their blood glucose
Diabetes how to treat diabetes during pregnancy
Geriatrics misuse of the Beers criteria to determine drug therapy in the elderly
Infectious Diseases new HIV drug, Selzentry (maraviroc)
Smoking Cessation retailers to remove Resolve from shelves
Pediatrics new recommendations for using vaccines containing thimerosal